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Vitamin D is a micronutrient that is needed for optimal health throughout the whole life.
Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to
the UV light of the sun, or it is obtained from the diet. If the photoconversion in the skin
due to reduced sun exposure (e.g., in wintertime) is insufficient, intake of adequate vitamin
D from the diet is essential to health. Severe vitamin D deficiency can lead to a multitude
of avoidable illnesses; among them are well-known bone diseases like osteoporosis,
a number of autoimmune diseases, many different cancers, and some cardiovascular
diseases like hypertension are being discussed. Vitamin D is found naturally in only very
few foods. Foods containing vitamin D include some fatty fish, fish liver oils, and eggs from
hens that have been fed vitamin D and some fortified foods in countries with respective
regulations. Based on geographic location or food availability adequate vitamin D intake
might not be sufficient on a global scale. The International Osteoporosis Foundation (IOF)
has collected the 25-hydroxy-vitamin D plasma levels in populations of different countries
using published data and developed a global vitamin D map. This map illustrates the
parts of the world, where vitamin D did not reach adequate 25-hydroxyvitamin D plasma
levels: 6.7% of the papers report 25-hydroxyvitamin D plasma levels below 25nmol/L,
which indicates vitamin D deficiency, 37.3% are below 50nmol/Land only 11.9% found
25-hydroxyvitamin D plasma levels above 75 nmol/L target as suggested by vitamin D
experts. The vitamin D map is adding further evidence to the vitamin D insufficiency
pandemic debate, which is also an issue in the developed world. Besides malnutrition,
a condition where the diet does not match to provide the adequate levels of nutrients
including micronutrients for growth and maintenance, we obviously have a situation where
enough nutrients were consumed, but lacked to reach sufficient vitamin D micronutrient
levels. The latter situation is known as hidden hunger. The inadequate vitamin D status
impacts on health care costs, which in turn could result in significant savings, if corrected.
Since little is known about the effects on the molecular level that accompany the pandemic
like epigenetic imprinting, the insufficiency-triggered gene regulations or the genetic
background influence on the body to maintain metabolic resilience, future research will
be needed. The nutrition community is highly interested in the molecular mechanism
that underlies the vitamin D insufficiency caused effect. In recent years, novel large
scale technologies have become available that allow the simultaneous acquisition of
transcriptome, epigenome, proteome, or metabolome data in cells of organs. These
important methods are now used for nutritional approaches summarized in emerging
scientific fields of nutrigenomics, nutrigenetics, or nutriepigenetics. It is believed that with
the help of these novel concepts further understanding can be generated to develop future
sustainable nutrition solutions to safeguard nutrition security.
Keywords: vitamin D, 25-hydroxyvitamin D, nutrition, micronutrients, hidden hunger, nutrition security, nutritional
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INTRODUCTION
Vitamin D is needed to maintain calcium concentrations within
a narrow physiological range. This function is vital as the cal-
cium ion is essential for a large variety of cellular and metabolic
processes in the body (Berridge, 2012). To secure the calcium
supplies besides intestinal absorption, calcium is stored in the
skeleton and acts as a large calcium reservoir that is mainly
controlled by PTH and vitamin D (Bouillon et al., 2014). Humans
produce vitamin D by exposure to sunlight that includes ultra-
violet B radiation; if ultraviolet B radiation is not available in
sufficient amounts, vitamin D needs to be obtained from the
diet or dietary supplements (Holick, 2007). The start of the
vitamin D endocrine system is believed to have been initiated
before the start of vertebrates and evolved over millions of years
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(Bouillon and Suda, 2014). Therefore, the vitamin D micronutri-
ent either synthesized through the sun by the skin or through
dietary uptake is well-adapted to the human body. The endoge-
nously conjugated vitamin D metabolites have taken over many
important roles in the maintenance of human health, of which
many still await to be discovered.
In this paper, we summarize the knowledge on vitamin D as an
essential micronutrient important for human health and discuss
the new nutritional research on its way to gain further knowledge
on the function of vitamin D for nutrition.
VITAMIN D PART OF NUTRITION AND CONTENT IN FOODS
The history of vitamin D is linked to first scientific description
of the classic bone disease rickets by Whistler in 1645 (Norman,
2012). Two centuries later it was Schütte who observed the useful-
ness of cod liver oil in the treatment of rickets and osteomalacia
in 1824. The hunt for the anti-rachitic factor ended in early twen-
tieth century, when Mellanby could demonstrate in a series of
hallmark studies (1919–1924) that a nutritional component in
the diet was the anti-rachitic factor to prevent rickets (Mellanby,
1919, 1976; Platt, 1956). Shortly after, vitamin D was inaugu-
rated without the characterization of the chemical structure. In
1919, Hudschinsky showed in parallel that UV light was able to
ameliorate rickets by increasing calcification in rachitic children
(Huldschinsky, 1919, 1926). Both findings of the cod liver oil and
the UV light preventing rickets remained independent observa-
tions until Hess and Weinstock elegantly could demonstrate that
the anti-rachitic vitamin D was produce by UV irradiation in skin
(Hess and Weinstock, 1925a,b). In 1936, Windaus and colleagues
determined the chemical structure of the fat-soluble seco-steroid
vitamin D (Windaus et al., 1936).
The vitamin D definition comprises a group of molecules
called the calciferols. The main forms present in foods are chole-
calciferol (vitamin D3) and ergocalciferol (vitamin D2), whereas
the metabolite 25-hydroxycholecalciferol (25-hydroxyvitamin
D3) is a natural part of the food chain by its occurrence in animal
products. Vitamin D3 is unique by the fact that the same nutrient
can be synthesized in the skin through the action of sunlight or
being taken up by diet. This dual source of intake secures the body
to maintain sufficient vitamin D levels in the body. The produc-
tion in skin is usually the major vitamin D3 source for the body.
However, in countries that receive insufficient sun exposure, peo-
ple rely on dietary vitamin D as a major source. Exposure of the
precursor 7-dehydrocholesterol in the basal and suprabasal layers
of the epidermis to ultraviolet B (UVB) light with a wavelength
of 290–315 nm is needed for the formation of the previtamin
D3. The subsequent conversion is a non-enzymatic process that
includes a thermal isomerization of the previtamin D3 to pro-
duce vitamin D3 (Collins and Norman, 2001; Holick, 2011). This
vitamin D3 is rapidly converted to 25-hydroxyvitamin D3 in the
liver. The vitamin D status is evaluated by measuring the circu-
lating levels of serum 25-hydroxyvitamin D, which is the sum of
cutaneous synthesis (vitamin D3) or dietary contribution (vita-
min D3 and vitamin D2). The 25-hydroxyvitamin D3 needs to
be further hydroxylated in the kidney (or locally in other organs
Lehmann et al., 2001) to form 1,25-dihydroxyvitamin D3, the
active endogenous hormone, which is responsible for most of
the physiological actions of vitamin D through the binding to
the vitamin D receptor (VDR). The plant-derived vitamin D2 is
processed in the same way. For both vitamers, vitamin D2, and
vitamin D3, the consecutive molecular action is believed to be
identical, whereas only 1,25-dihydroxy vitamin D3 is the endoge-
nous hormone, the activated vitamer 1,25-dihydroxyvitamin D2
is hormone mimetic. Therefore, it was not surprising that vita-
min D3 has been reported to be superior to vitamin D2 in
terms of bioavailability and maintaining the vitamin D status by
the majority of studies (Trang et al., 1998; Armas et al., 2004;
Romagnoli et al., 2008; Glendenning et al., 2009; Heaney et al.,
2011; Lehmann et al., 2013). Only one study reported that the
two vitamers were essentially equipotent (Holick et al., 2008).
The level of cutaneous vitamin D3 synthesis is mainly affected
by the amount of solar UVB radiation reaching the human skin,
which is a function that needs to take into account the wavelength,
thickness of the ozone layer in the atmosphere and solar zenith
angle. Furthermore, the geographic latitude, season of the year
and time of day influence and restrict the skin-borne synthesis
of vitamin D3 (Webb et al., 1988; Holick, 2011). It was described
that vitamin D3 synthesis in the skin declines with age, which is
due in part to a fall of 7-dehydrocholesterol and the morpholog-
ical changes due to biological aging (MacLaughlin and Holick,
1985; Holick et al., 1989). Matsuoka et al. (1991) have shown
that in Caucasians and Asian subjects having a lighter skin pig-
mentation UVB radiation produce significantly higher vitamin
D3 serum levels than in African American and East Indian groups.
It is not of a surprise that skin pigmentation reduces vitamin D3
formation. This skin tone dependent down regulation is easily
overcome by increased sun exposures (Armas et al., 2007). Apart
to darker pigmented skin, cutaneous vitamin D3 production can
be reduced for many other reasons like severe air pollution in
large cities, less outdoor activity as a consequence of an unhealthy
lifestyle change, immobility of institutionalized elderly popula-
tions, topical application of sunscreens with a high sun protection
factors or cultural dress codes (e.g., veiling). Therefore, dietary
intake of vitamin D through foods or supplements plays a vital
part to maintain healthy vitamin D levels.
Through nutrition, vitamin D intake is limited. There are
few naturally-occurring food sources containing relevant levels of
vitamin D. Table 1 summarizes the vitamin D content in selected
foods. Vegetarian diets are limited to the plant vitamin D2 that
is only present in some mushrooms. Commercially dark culti-
vated white button mushrooms contain low amounts of vitamin
D2, only wild mushrooms or sun-dried mushrooms contain ele-
vated amounts of ergocalciferol (Mattila et al., 1994, 1999b, 2001;
Teichmann et al., 2007). Some commercial producers include an
UVB radiation step to increase the vitamin D2 content in their
products (Mau et al., 1998; Roberts et al., 2008). Vitamin D2
is formed out from ergosterol in the mushrooms. Some plants
that are used as foods however can contain ergosterol, but this
provitamin form is not converted to vitamin D2. Vitamin D3
is not found in food-borne plants. In plants, the occurrence of
vitamin D3-related compounds is scarce. Interestingly, species
belonging to the botanical Solanaceae family, like Solanum mala-
coxylon (Solanum glaucophyllum and Solanum glaucum), contain
a glycoside of the active 1,25-dihydroxyvitamin D3 hormone
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Table 1 | Vitamin D content in raw products, processed foods, and fortified foods.
Category Foodstuff Range References
(µg vitamin D (IU vitamin D
per 100g) per 100g)
RAW PRODUCTS
Fish Herring 2.2–38.0 88–1,520 Kobayashi et al., 1995; Mattila et al., 1995a, 1997; Ostermeyer
and Schmidt, 2006; Byrdwell et al., 2013
Salmon 4.2–34.5 168–1,380 Kobayashi et al., 1995; Ostermeyer and Schmidt, 2006; Lu et al.,
2007; Byrdwell et al., 2013
Halibut 4.7–27.4 188–1,094 Ostermeyer and Schmidt, 2006; Byrdwell et al., 2013
Perch 0.3–25.2 12–1,012 Mattila et al., 1995a, 1997; Ostermeyer and Schmidt, 2006;
Byrdwell et al., 2013
Trout 3.8–19.0 152–760 Mattila et al., 1995a; Ostermeyer and Schmidt, 2006; Byrdwell
et al., 2013
Tuna 1.7–18.7 68–748 Takeuchi et al., 1984, 1986; Kobayashi et al., 1995; Byrdwell
et al., 2013
Mackerel 0.5–15.5 20–620 Egaas and Lambertsen, 1979; Aminullah Bhuiyan et al., 1993;
Kobayashi et al., 1995; Ostermeyer and Schmidt, 2006; Lu et al.,
2007
Cod 0.5–6.9 20–276 Kobayashi et al., 1995; Mattila et al., 1995a; Ostermeyer and
Schmidt, 2006; Byrdwell et al., 2013
Mushrooms Morel 4.2–6.3 168–252 Phillips et al., 2011
Dark cultivated white
bottom mushrooms
0–0.2 0–8 Mattila et al., 2001; Teichmann et al., 2007; Phillips et al., 2011
Wild grown mushrooms 0.3–29.8 10–1,192 Mattila et al., 1994, 1999b, 2001; Kobayashi et al., 1995;
Teichmann et al., 2007
Animal products Pork meat 0.1–0.7 4–28 Kobayashi et al., 1995; Bilodeau et al., 2011; Strobel et al., 2013
Beef meat 0–0.95 0–38 Kobayashi et al., 1995; Montgomery et al., 2000, 2002; Bilodeau
et al., 2011; Strobel et al., 2013
Chicken meat 0–0.3 0–12 Kobayashi et al., 1995; Mattila et al., 1995b; Bilodeau et al., 2011;
Strobel et al., 2013
Beef liver 0–14.1 0–560 Kobayashi et al., 1995; Mattila et al., 1995b; Montgomery et al.,
2000, 2002
Eggs 0.4–12.1 28–480 Mattila et al., 1992, 1999a; Kobayashi et al., 1995; Bilodeau et al.,
2011; Exler et al., 2013
PROCESSED FOODS
Fish Tuna (skipjack) liver oil 144,400 5,776,000 Takeuchi et al., 1984
Halibut liver oil 13,400 536,000 Egaas and Lambertsen, 1979
Cod liver oil 137.5–575.0 5,500–23,000 Egaas and Lambertsen, 1979; Takeuchi et al., 1984
Canned pink salmon 12.7–43.5 508–1,740 Bilodeau et al., 2011
Canned sardines 3.2–10 128–400 Mattila et al., 1995a
Smoked salmon 4.9–27.2 196–1,088 Ostermeyer and Schmidt, 2006
Mushrooms Irradiated mushrooms 6.6–77.4 264–3,094 Mau et al., 1998; Roberts et al., 2008
Dairy Butter 0.2–2.0 8–80 Kobayashi et al., 1995; Mattila et al., 1995b; Jakobsen and
Saxholt, 2009
Cheese 0–0.1 0–4 Mattila et al., 1995b; Wagner et al., 2008
FORTIFIED FOODS
Cereals Corn flakes 2–4.7 87–189 Haytowitz et al., 2009; U.S. Department of Agriculture, 2013
Beverages Orange juice 1.1 44 Wacker and Holick, 2013
Malted drink mix,
powder
3 123 Haytowitz et al., 2009; U.S. Department of Agriculture, 2013
Dairy Milk 1.1–2.0 42–79 Calvo et al., 2004; Haytowitz et al., 2009; U.S. Department of
Agriculture, 2013
Cheese 2.6–25.0 102–1,000 Haytowitz et al., 2009; Tippetts et al., 2012; U.S. Department of
Agriculture, 2013
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(Boland, 1986; Boland et al., 2003; Japelt et al., 2013). This decid-
uous shrub (1.5–3.0m stem length) is widely distributed in the
provinces of Buenos Aires in Argentina and in Brazil and is
responsible for the calcinotic disease in cattle and other grazing
animal.
Animal food products are the main dietary source for natu-
rally occurring vitamin D3 (Schmid andWalther, 2013). Since the
discovery of vitamin D, vitamin D was associated with oily fish
products. It was driven by the early observation that the amount
of vitamin D in a teaspoon of cod liver oil was sufficient to pre-
vent rickets in infants. It is still the fish liver oil that contains the
highest amounts of vitamin D3. The highest reported concentra-
tion was found in skipjack liver oil 144,400μg/100 g (Takeuchi
et al., 1984). The fish liver oils besides other nutritional ingre-
dients might contain high levels of vitamin A. The vitamin A to
vitamin D ratio in the fish liver oils is species and fishing area
dependent. The ratio range starts with a factor of 0.5 for skip-
jack liver oil and can even reach an extreme ratio of 119 (pollack
liver oil) (Takeuchi et al., 1984). This wide vitamin A to vitamin D
ratio range is the reason why fish liver oils often need further pro-
cessing. In fresh fish products we observe a huge variation in the
vitamin D3 content per 100 g wet weight (Egaas and Lambertsen,
1979; Takeuchi et al., 1984, 1986; Kobayashi et al., 1995; Mattila
et al., 1995a, 1997; Ostermeyer and Schmidt, 2006; Lu et al., 2007;
Byrdwell et al., 2013) (Table 1). Large variations in vitamin D3
content were found within the same species, but also between the
different fish species. Fish obtain their vitamin D3 requirements
through their diet (Holick, 2003). Therefore, the vitaminD3 levels
in the zooplankton, the primary food source of fish, or seasonal
changes in the zooplankton reservoirs in the different habitats,
might be the reasons for the observed fluctuation in the fish prod-
uct. Interestingly, the weight, the sex, or the age of the fish could
not be correlated to the vitamin D3 content. Furthermore, no sig-
nificant correlation between the tissue fat content and vitamin D
levels was detected (Mattila et al., 1995a, 1997). Significant dif-
ferences in vitamin D3 content were found between muscle and
skin tissues and even more pronounced between muscle and liver
tissues (Takeuchi et al., 1986). The 25-hydroxyvitamin D3 com-
pound was also detected, though at low concentrations (Takeuchi
et al., 1986; Mattila et al., 1995a; Ovesen et al., 2003; Bilodeau
et al., 2011).
Wild and sun-dried mushrooms can be a good dietary source
of vitamin D2 (Mattila et al., 1994, 1999b, 2001; Kobayashi et al.,
1995; Teichmann et al., 2007; Phillips et al., 2011). However,
the commercially produced mushrooms, e.g., the white button
mushroom, do not contain or contain only very low amounts of
vitamin D2 (Mattila et al., 2001; Teichmann et al., 2007; Phillips
et al., 2011). The vitamin D2 content in commercially produced
mushrooms can be increased by UVB exposure during the cul-
turing or the postharvest process (Mau et al., 1998; Roberts et al.,
2008). The concentration of vitamin D in eggs can vary from 0.4
to 12.1μg (Parrish, 1979; Mattila et al., 1992, 1999a; Bilodeau
et al., 2011; Exler et al., 2013), it is in a similar range like offal
(Mattila et al., 1995b; Montgomery et al., 2000, 2002). Other ani-
mal products like pork, beef, and chicken muscle meat are low
in vitamin D content (Mattila et al., 1995b; Montgomery et al.,
2000, 2002; Bilodeau et al., 2011; Strobel et al., 2013). By adding
vitamin D3 into the feed, the vitamin D3 content can be increased
in muscle and liver of cattle, to 4.6μg per 100 g of tissue and
99.6μg per 100 g of tissue, respectively (Montgomery et al., 2004).
Milk, unless fortified, has been shown to contain no or very
little amounts of vitamin D, whereas in dairy products like but-
ter and cheese the vitamin D content is higher, but in serving
size amounts still very low (Kobayashi et al., 1995; Mattila et al.,
1995b; Jakobsen and Saxholt, 2009; Trenerry et al., 2011). In gen-
eral, household cooking seems to have some effect on vitamin
D stability depending on the actual foodstuffs and the heat-
ing process used (Mattila et al., 1999b; Jakobsen and Knuthsen,
2014).
To meet the vitamin D needs in the countries some states
fortify foods. Dairy products are ideal for vitamin D fortifica-
tion. In Canada vitamin D fortification is mandatory for milk
(1μg/100ml) and margarine (13.3μg/100 g) (Health Canada,
2014). In other countries, like the United States, vitamin D for-
tification is optional for products like milk, breakfast cereals,
and fruit juices (Calvo et al., 2004). In the U.S. Department
of Agriculture (2013) of the US Department of Agriculture
(USDA)’s Nutrient Databank System (Haytowitz et al., 2009),
5036 foods have been determined for their vitamin D content, of
which only 259 food items had detectable vitamin D levels. The
data showed that per serving only seven fish products had>15μg
vitamin D. All 29 foods that contained between 2.5μg 15μg vita-
min D per serving were either fortified foods (21) or fish produce
(8). Two-thirds of all vitamin D containing foods were far below
the 1.0μg level, whereas 20 percent had even negligible vitamin
D content per serving (below 0.1μg).
Despite the fact that moderate sun exposure of arms and legs
in summer for 5–30min between the hours of 10 a.m. and 3 p.m.
twice a week is enough to produce sufficient vitamin D3 in the
body (Holick, 2007), it is astonishing that many populations that
live at these privileged latitudes fail to achieve this goal (Holick
and Chen, 2008; Lips, 2010; Wahl et al., 2012; Hilger et al., 2014).
During winter time, when vitamin D3 production by the sun
ceased, adequate vitamin D levels can only be achieved by UVB
exposure from indoor tanning units, or by a daily diet of for-
tified foods or a few selected food items. This restricted list of
options to achieve sufficient levels is one of the reasons, why the
use of dietary vitamin D supplements has become so popular. It
is currently the most applied and secure option to reach adequate
vitamin D intake levels (Holick, 2007).
VITAMIN D MAP, MALNUTRITION, HIDDEN HUNGER, AND
NUTRITION SECURITY
An accepted biomarker for the vitamin D status in the gen-
eral population is to measure the serum concentration of
25-hydroxyvitamin D levels, which is the major circulating form
of vitamin D and reflects both dietary vitamin D intake and
the endogenous vitamin D production (Lips, 2001, 2007). The
serum concentration of 25-hydroxyvitamin D is linked to the
serum level of the active hormone 1,25-dihydroxyvitamin D and
also to the clinical relevant parathyroid hormone level. Lips has
classified the 25-hydroxyvitamin D levels into four stages (Lips,
2001; Lips et al., 2013): severe deficiency (<12.5 nmol/L), defi-
ciency (12.5–25 nmol/L), insufficiency (25–50 nmol/L), repletion
Frontiers in Physiology | Integrative Physiology July 2014 | Volume 5 | Article 248 | 4
Bendik et al. Vitamin D an important micronutrient
(>50 nmol/L). The thresholds for severe deficiency and deficiency
are undisputed; however, a controversy has arisen for defining the
border between insufficiency and repletion. In 2011, the Institute
of Medicine (IOM) suggested a serum level of 50 nmol/L as the
value at which 97.5% of the vitamin D needs of the popula-
tion would be covered (Institute of Medicine, 2011; Ross et al.,
2011), whereas, the Endocrine Society (ES) defined it to be higher:
75 nmol/L (Holick et al., 2011). All deficiency levels including
insufficiency, as so-called mild deficiency, must be prevented
through focused supplementation.
In 2010, the Institute of Medicine (IOM) introduced new
dietary reference intake (DRI) values for vitamin D after com-
prehensive reviewing of more than 1000 high quality research
articles to renew thereby their first settings from 1997 (Institute of
Medicine, 2011). The DRIs address an adequate nutritional intake
of all sources. The IOMhas set the dietary allowance (RDA) to 600
IU per day for the general population and at 800 IU per day for
persons 70 years and older, whereas 1 IU is the biological equiv-
alent of 0.025μg vitamin D3. The tolerable upper intake level or
UL (Upper Level of Intake), which represents the safe upper limit,
was set to 4000 IU per day for vitamin D intake (Ross et al., 2011).
The new RDAs reflect the scientific outcome from large dietary
studies that revealed vitamin D insufficiency (Looker et al., 2002;
Zadshir et al., 2005). In 2012, Troesch et al. analyzed the vitamin
intake from different dietary surveys that included the German
Nutritional Intake Study (Nationale Verzehrstudie II) 2008 (Max
Rubner-Institut, 2008), the US National Health and Nutrition
Examination Survey (NHANES) from 2003 to 2008 (Centers for
Disease Control and Prevention & National Center for Health
Statistics, 2009), the UK (The British National Diet and Nutrition
Survey, 2003) (Henderson et al., 2003) and the Netherlands (van
Rossum et al., 2011), and could confirm that vitamin D is one of
the critical vitamins, which intake is below the recommendation
(Troesch et al., 2012).
A gap exists between the intake and the recommendation
of vitamin D. The chronic insufficient intake of micronutrients
like vitamin D without seeing immediate clinical signs is called
Hidden Hunger. Hidden Hunger, in particular for vitamin D,
is more prevalent in the populations of the developed coun-
tries as anticipated (Biesalski, 2013). Hidden Hunger is a threat
for the nutrition security for a given country. Nutrition security
mandates sufficient micronutrients in an adequate food supply
and is required to safeguard an optimal nutritional status of a
population.
Many groups have identified vitamin D deficiency or insuf-
ficiency to become a public health problem worldwide (Holick,
2007; Holick and Chen, 2008; Mithal et al., 2009; Lips and Van
Schoor, 2011; Wahl et al., 2012; Hilger et al., 2014). Mithal et al.
(2009) described in their global report that most populations
do not achieve a desirable vitamin D status and particular peo-
ple at risk and elderly people suffer from vitamin D deficiency.
In two reports, the International Osteoporosis Foundation (IOF)
and its partners published the global vitamin D status map (Wahl
et al., 2012; Hilger et al., 2014). The vitamin D map was based
on a systematic review of the worldwide vitamin D levels, using
all available publications published between 1990 and February
2011 (Hilger et al., 2014). Eligible studies include 168,389 par-
ticipants from the general populations throughout the world
where the mean or median serum 25-hydroxyvitamin D levels
were measured. Studies included had a cross-sectional design or
were based on a population based cohorts. The analysis identi-
fied nearly 200 studies from 44 countries, whereas only half of
the studies were included in the global vitamin D status map as
50.2% of the studies were not representative for the target pop-
ulations. Figure 1 shows the global vitamin D status map listed
by countries and by continents. The largest numbers of studies
were performed in Europe, followed by North America and Asia-
Pacific. Available data from Latin America and even more from
Africa are limited. Results of this review showed that 6.7% of the
population were vitamin D deficient (mean 25-hydroxyvitamin D
values<25 nmol/L), 37.3%were vitamin D insufficient according
to IOM (mean values below 50 nmol/L) and 88.1% of the popula-
tion showed an insufficient vitamin D status according to the ES
(mean values below 75 nmol/L). No significant differences were
found for gender or age, when looking at the worldwide data, but
some regional differences could be identified (Hilger et al., 2014).
The 25-hydroxyvitamin D serum levels were higher in Europe and
the US, when compared to Middle East and Africa. This might
be due to the vitamin D food fortification programs in North
America (Prentice, 2008). Furthermore, the systematic analysis
revealed that institutionalized elderly were more at risk to have
low 25-hydroxyvitamin D levels in Europe and Asia/Pacific. The
compared non-institutionalized elderly group showed higher lev-
els, possibly due to spending more of time outdoors. The group
of institutionalized elderly is therefore at high risk to become
vitamin D deficient. Further research is needed to inform pub-
lic health policy makers to reduce the risk for potential health
consequences of low vitamin D status.
In the past few years the national recommendations for dietary
vitamin D were adjusted in several countries; they are not harmo-
nized across the European Union yet and vary from 200 to 800
IU. The higher recommendations for dietary vitamin D intake
are increasingly being suggested in government documents, posi-
tion statements and clinical practice guidelines for bone health. In
2008, the US Food and Drug Administration updated the health
claim for the prevention of osteoporosis by including vitamin D
to the consumption of calcium (Food and Drug Administration,
2008). In 2008, the American Academy of Pediatrics also reacted
and issued an update of their guidelines for vitamin D intake and
rickets prevention (Perrine et al., 2010). They doubled the rec-
ommended dose of vitamin D for children to 400 IU per day,
beginning in the first few days of life and continuing throughout
adolescence. In 2010, the Institute ofMedicine (IOM) released the
revised Dietary Reference Intakes (DRI’s) for calcium and vitamin
D and tripled the recommendations for vitamin D intakes to 600
IU per day for children and all adults up to age 69 years (Institute
of Medicine, 2011). The IOM stated that there was insufficient
evidence to make recommendations for non-skeletal benefits.
In 2012, the German, Austrian, and Swiss Nutrition Societies
raised the recommended vitamin D intake to 800 IU per day, in
case of absent UVB exposure, for all age groups starting from
1 year of age (German Nutrition Society, 2012). Furthermore,
key opinion leaders are increasingly recommending higher daily
intakes for vitamin D, between 800 and 1000 IU or even higher for
people at risk or older adults. The recent statement by the IOF and
the guidelines by the US ES suggest that higher vitamin D doses
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FIGURE 1 | Overview of published 25-hydroxyvitamin D mean/median
values by countries (modified from Hilger et al., 2014). The color
trend from red, yellow to green shown above the graphical diagram
represents the current uncertainty around the definition of
25-hydroxyvitamin D3 serum thresholds starting from severe deficiency
(red), deficiency, insufficiency to total repletion (green). The reported
means are shown as black circles, studies that reported medians are
given in gray circle. The study size is indicated by the circle size.
Mean/median values falling within the intensely red zone are most
consistent with severe vitamin D deficiency.
would be needed to achieve the desirable 25-hydroxyvitamin
D serum level of 75 nmol/L for people at risk or older
individuals.
Increasing the vitamin D levels in the population would
also ameliorate health economics. Grant and colleagues cal-
culated the benefit of increasing vitamin D levels to reduce
the economic burden of diseases (Grant et al., 2009). A rise
in the vitamin D serum level of all Europeans to 40 nmol/L
would reduce the economic burden of different diseases and
could save health care costs of up to 16.7%. Besides reduc-
ing the economic costs, vitamin D intake could in addition
also reduce mortality rates and maintain a longer healthy life
style.
NUTRITIONAL RESEARCH TO ADDRESS AND UNDERSTAND
VITAMIN D INSUFFICIENCY
Vitamin D deficiency is undoubtedly linked to severe conse-
quences in the growing child by causing incomplete mineral-
ization of the bone and in the adult accounting to wasteful
osteomalacia. In the vitamin D insufficiency stage, this severity
gets gradually less, but the outcome remains unchanged. Besides
the established and accepted functional skeletal health relation-
ship, more and more evidence is accumulating for falls (Pfeifer
et al., 2000, 2009; Bischoff et al., 2003; Flicker et al., 2005; Broe
et al., 2007; Prince et al., 2008; Bischoff-Ferrari et al., 2009) and
physical performance (Bischoff-Ferrari et al., 2004; Houston et al.,
2011; Ceglia et al., 2013; Redzic et al., 2013; Sohl et al., 2013;
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Tieland et al., 2013), which has been recognized by a health claim
of the European Food and Safety Authority in 2011: “Vitamin D
may reduce the risk of falling. Falling is a risk factor for bone frac-
tures.” This health claim is targeting men and women 60 years
of age and older and the dose required is a daily consumption
of 800 IU vitamin D, which can come from all sources. Further
emerging vitamin D health relationships include physiological
parameters like improved immune response (Baeke et al., 2010;
Schwalfenberg, 2011; Hewison, 2012;White, 2012), improved res-
piratory health(Berry et al., 2011; Charan et al., 2012; Choi et al.,
2013; Hirani, 2013) possibly also relate to reduced tuberculosis
incidence (Nnoaham and Clarke, 2008; Martineau et al., 2011;
Mitchell et al., 2011; Coussens et al., 2012; Salahuddin et al.,
2013; Huaman et al., 2014); and reduced risk to develop autoim-
mune diseases like multiple sclerosis (Solomon and Whitham,
2010; Cantorna, 2012; Dobson et al., 2013) or type 1 diabetes
(Hypponen et al., 2001; Holick, 2003; Ramos-Lopez et al., 2006;
Baeke et al., 2010; De Boer et al., 2012; Dong et al., 2013; Van Belle
et al., 2013). In chronic, non-communicable diseases, vitamin D
deficiency is being discussed to possibly ameliorate the incidence
of some neoplastic diseases like colorectal, lung, prostate, and
breast cancers (Ng et al., 2008; Rosen et al., 2012; Welsh, 2012;
Cheng et al., 2013); cardiovascular diseases (CVDs) including
hypertension, myocardial infarction, stroke (Forman et al., 2007;
Giovannucci et al., 2008; Gardner et al., 2011; Bischoff-Ferrari
et al., 2012; Tamez and Thadhani, 2012; Karakas et al., 2013; Pilz
et al., 2013a; Schroten et al., 2013); life-style diseases like obesity
and type 2 diabetes (Pittas et al., 2007; González-Molero et al.,
2012; Khan et al., 2013; Pilz et al., 2013b; Schottker et al., 2013;
Tsur et al., 2013; Van Belle et al., 2013; Bouillon et al., 2014); dis-
eases related to the decline in sight function including age-related
macular degeneration (Parekh et al., 2007; Millen et al., 2011; Lee
et al., 2012); and neurological disorders including Alzheimer and
Parkinson disease (Buell and Dawson-Hughes, 2008; Annweiler
et al., 2012; Eyles et al., 2013; Zhao et al., 2013). One may wonder
about the width of possible implications being looked at, but con-
sidering the more than 1000 genes which vitamin D is regulating
through the VDR (Carlberg and Campbell, 2013), this may actu-
ally not be a surprise. To determine the potential role of vitamin D
supplementation in the prevention or treatment of chronic non-
skeletal diseases notwithstanding, large-scale clinical trials are
demanded. In this respect for the nutrition field, four new large-
scale ongoing long-term supplementation studies are expected to
deliver results in near future (Table 2). The two very large stud-
ies, VITAL trial (n = 20, 000) and FIND study (n = 18, 000), are
meant to deliver clinical evidence for the effect of vitamin D3
on cancer, CVD and diabetes outcomes. The two smaller trials,
CAPS and DO-HEALTH, each having more than 2,000 partic-
ipants are including cancer, infections, fractures, hypertension,
cognitive function, and physical performance outcomes. In all
four studies the placebo groupwill produce vitaminD3 in the skin
and will possibly consume vitamin D through food, and there-
fore this will narrow the vitamin D serum level gap between the
placebo and treatment groups. It remains to be seen whether the
applied supplementation doses (2000 IU and 1600 IU, 3200 IU)
will be sufficient to see a clear difference between the treatment
and the control groups. An open likelihood will remain for the
placebo group potentially obtaining sufficient vitamin D3 (600–
800 IU) levels that are considered to be sufficient for skeletal
effects. In such a case only an incremental increase of an addi-
tional∼1000 IU can be considered as the effective dose, for which
no power calculation was available at the time before study begun.
In light of such a situation, it will be of interest whether the
micronutrient triage theory of Bruce Ames can be validated with
vitamin D3 (Ames, 2006; McCann and Ames, 2009). The triage
theory postulates, as a result of recurrent shortages of micronu-
trients during evolution, that the body has selected and developed
a metabolic rebalancing response to shortage. These rebalanc-
ing favored micronutrient-needs for short term survival, while
those only required for long-term health were starved. In the case
of the micronutrient vitamin D3, calcium and bone metabolism
can be considered to be secured with highest priority, there-
fore, it might be speculated that the 600–800 IU intake would
satisfy this vitamin D3 serum level threshold. For the chronic
non-skeletal diseases however, which have only secondary prior-
ity in an evolutionary perspective, higher serum vitamin D3 levels
would be required. The ongoing four vitamin D3 studies that have
chronic diseases as their main outcomes and use nutritionally rel-
evant ∼2000 IU are therefore well-suited to address whether the
triage theory holds also true for the micronutrient vitamin D3.
Vitamin D3 once in the blood immediately binds to the vita-
min D-binding protein (DBP) and gets transported into the
liver (Holick, 2007). The first hydroxylation at position 25 gen-
erates the major circulating metabolites 25-hydroxyvitamin D3.
This metabolite circulates throughout all organs and undergoes
hydroxylation at position 1, which occurs mainly in the kid-
ney, but also in other organs, to form 1,25-dihydroxyvitamin
D3, the active hormone. Besides the major circulating metabo-
lite 25-hydroxyvitamin D3 and the hormonally active metabo-
lite 1,25-dihydroxyvitamin D3, more than 35 additional vitamin
D3 metabolites are formed by the body (Bouillon et al., 1995;
Norman et al., 2001). It is speculated that they might be interme-
diates in the catabolism of 1,25-dihydroxyvitaminD3. The human
body has evolved many CYP enzymes and invests energy to form
these additional 35 vitamin D3 metabolites, whether this is for the
purpose to catabolize 1,25-dihydroxyvitamin D3, remains still to
be answered. More appealing is the theory that these metabolites
are formed to fulfill yet unknown functions of vitamin D3. This
perspective could potentially also account to the pleiotropic non-
skeletal health benefits reported by the many vitamin D intake
studies. For some of the vitamin D3 metabolites like the 24R,25-
dihydroxyvitamin D3 potential function was explored in vitro
(Norman et al., 2002).
The 24R,25-dihydroxyvitamin D3 has been shown to be an
essential hormone in the process of bone fracture healing. The
24R,25-dihydroxyvitamin D3 most likely initiates its biological
responses via binding to the ligand binding domain of a postu-
lated cell membrane receptor VDRmem24,25, similar to the better
studied, but still not cloned cell membrane receptor for 1,25-
dihydroxyvitamin D3, VDRmem1,25 (Norman et al., 2002). From
the nutritional point of view, it will be of interest to investigate
the function of the all vitamin D3 metabolites and relate the func-
tion to the level of vitamin D3 intake to secure the health benefit
according to the triage theory.
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According to the current knowledge, the vitamin D endocrine
system is funneled through the biologically most active metabo-
lite 1,25-dihydroxyvitamin D3 that is mainly produced in
the kidney, but also in other organs (Bouillon et al., 2013).
Mechanistically 1,25-dihydroxyvitamin D3 binds the VDR
directly on a DNA sequence, the 1,25-dihydroxyvitamin D3
response element (VDRE), in the regulatory region of pri-
mary 1,25-dihydroxyvitamin D3 target genes (Carlberg and
Campbell, 2013). The VDR forms together with the retinoid
X receptor or putative other transcription factors a het-
erodimer on the VDRE, recruiting tissue-specific transcriptional
co-activators and regulates through a conformational change
upon 1,25-dihydroxyvitamin D3 binding the downstream gene.
The VDR is widespread in more than 30 tissues (Bouillon et al.,
1995) and may trigger expression of more than 1000 genes
through 1,25-dihydroxyvitamin (Carlberg et al., 2013; Hossein-
Nezhad et al., 2013). The regulation of tissue-specific gene expres-
sion by 1,25-dihydroxyvitamin D3 is of high interest, as it guides
us toward the better understanding of the mechanistic action
of vitamin D3 in the different tissues. The gained knowledge
from the mechanistic studies can help to design smaller and
more focused nutritional intervention RCTs to answer whether
vitamin D contributes to a specific health benefit of interest.
In this respect the GeneChip-based transcriptomics methodol-
ogy using high-density microarrays demonstrated the expres-
sion of genes in a variety of important functions of more than
100 different pathways that could be linked to vitamin D defi-
ciency (Bossé et al., 2007; Tarroni et al., 2012; Hossein-Nezhad
et al., 2013). The development of chromatin immunoprecipita-
tion (ChiP) methodology linked to site-specific PCR amplifica-
tion of the VDR bound genomic DNA fragment, and later the
methods using tiled microarrays (ChiP-chip) applying the first
unbiased genome-wide approach, which then was followed by
the massive parallel NGS sequencing approach of the immuno-
precipitated DNA segments, opened up new avenues to inves-
tigate 1,25-dihydroxyvitamin D3 target genes in selected tissues
(Ramagopalan et al., 2010; Heikkinen et al., 2011; Carlberg et al.,
2012, 2013; Pike et al., 2014). In an elegant study, Carlberg
et al. identified in samples of 71 pre-diabetic individuals of the
VitDmet study changes in serum 25-hydroxyvitamin D3 concen-
trations that were associated to primary vitamin D target genes
(Carlberg et al., 2013). Based on their finding the authors pro-
posed the genes CD14 and THBD as transcriptomics biomarkers,
from which the effects of a successful vitamin D3 supplementa-
tion can be evaluated. These biomarkers are potentially suitable
for displaying the transcriptomics response of human tissues to
vitamin D3 supplementation.
Epigenetic alterations of the genome refer to heritable and
modifiable changes in gene expression that are not affect-
ing the DNA sequence. They may be inherited as Mendelian,
non-Mendelian, or environmentally caused traits. One of the
1,25-dihydroxyvitamin D3 induced epigenetic modification was
shown for the hypo-methylating effect on the osteocalcin pro-
moter (Haslberger et al., 2006). 1,25-Dihydroxyvitamin D3 was
associated with the demethylation of the osteocalcin promoter
and induced the osteocalcin gene expression. The activity of
VDR can be modulated by epigenetic histone acetylation. The
VDR alone or in concert with other transcription factors can
recruit histone-modifying enzymes like histone acetyl trans-
ferases (HATs) or histone deacetylases (HDACs) and epigenically
direct transcriptional expression of downstream genes (Burrell
et al., 2011; Karlic and Varga, 2011; Sundar and Rahman, 2011;
Hossein-Nezhad et al., 2013). The trans-generational epigenetic
inheritance of vitamin D3 triggered epigenome modification is
not fully explored, however maternal vitamin D deficiency has
been discussed with adverse pregnancy outcomes or potential sus-
ceptibility for diseases (Burrell et al., 2011; Hossein-Nezhad and
Holick, 2012). For future nutritional research it would be of great
value to identify and validate epigenetic biomarkers that could
serve as risk assessment tool for vitamin D insufficiency related
susceptibility to develop a disease later in life.
Variations in vitamin D status have been shown to be related
to inheritance. The disparity of vitamin D levels according to
ethnicity given skin pigmentation is well-established (Cashman,
2014; Ng et al., 2014). Dark skinned population individuals have
compared to Caucasian descendants almost one-half the serum
concentrations of 25-hydroxyvitamin D (Nesby-O’dell et al.,
2002). From twin studies it has been estimated that the heritabil-
ity of genetic regulation of vitamin D levels to be between 23
and 80% (Dastani et al., 2013). In addition, large-scale genetic
association studies using linkage disequilibrium analysis have
identified genetic loci correlating with serum vitamin D level
within five candidate genes (Dastani et al., 2013). The identified
SNPs are within the 1alpha-hydroxylase of 25-hydroxyvitamin
D (CYP27B1) gene, the 25-hydroxylase of vitamin D (CYP2R1)
gene, the vitamin D carrier protein (GC) gene, the VDR gene, and
the cytochrome P-450 (CYP24A1) gene coding for an enzyme that
inactivates 1,25-dihydroxyvitamin D. It is important to note that
replication studies in separate populations have to follow to ver-
ify the validity of the identified SNPs. The SNP information will
provide the additional guidance toward a personalized nutritional
advice to reach a sufficient vitamin D status.
CONCLUSION AND FUTURE PERSPECTIVES
In the recent years the knowledge about vitamin D and its impli-
cations have extended far beyond its classical role in bone health
in either fields of basic research as well as in human trials. In par-
ticular, the evidence for the role of vitamin D in reducing the risk
of fractures as well as decreasing the risk for falling is convinc-
ing and authorities have responded to it. Besides a health claim
issued by the EFSA on the risk reduction for falling the dietary
intake recommendations have been significantly increased in sev-
eral countries such as the US and in Europe (Austria, Germany,
Switzerland). A number of other countries around the globe are in
the process of establishing new dietary intake recommendations
as well. It turns out that on average a daily intake of 600–800 IU
vitamin D appears to be required to meet fundamental needs of
the human body, for specific applications higher daily intakes may
be necessary, which will become clearer as the results of a number
of ongoing clinical studies will become available.
The obvious question to answer is: do people obtain the rec-
ommended amounts of vitamin D? The diet is typically only a
minor vitamin D source as only few food items contain relevant
amounts of vitamin D, such as fatty sea fish. The primary vitamin
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D source for humans is the vitamin D synthesis in the skin
from vitamin D precursors by the sunlight—provided the skin
is sufficiently exposed to strong enough sun radiation. Several
groups have reviewed the published results on 25-hydroxyvitamin
D serum levels the established marker of the vitamin D status,
showing that low 25-hydroxyvitamin D levels are found in many
cohorts around the world. A recent systematic review of the global
vitamin D status (Hilger et al., 2014) showed that 6.7% of the
overall populations reported deficient 25-hydroxyvitamin D lev-
els below 25 nmol/L, 37% had 25-hydroxyvitamin D levels below
50 nmol/L, and only 11% were above 75 nmol/L, which is con-
sidered an adequate status by the IOF and the ES. So a very
important task ahead of us is to find efficient ways to improve the
vitamin D status on the population level, be it by dietary means,
food fortification, or dietary supplements.
In addition, it will be very important to gather sound and
convincing evidence for the many additional implicated health
benefits of vitamin D besides the ones that already reached a
health claim status and to see which of them will actually hold
up. This will require appropriate human studies on the one hand,
and also involve the appropriate use of the novel experimental
approaches like nutrigenomics, nutrigenetics, and nutriepigenet-
ics on the other hand. In conclusion, the evidence we have for
vitamin D in human health is exciting, however we have to make
sure that appropriate measures are taken to improve the vitamin
D status to the levels required to be beneficial for human health.
In future, we will also need to further apply, exploit and invest in
novel, innovative and break-through technologies in the vitamin
D research to understand the underlying mechanisms by which
vitamin D is exerting so many effects in the human body, which
is knowledge needed to the purpose to obtain and secure optimal
public health through nutrition.
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